Microtomes Market Size, Share, Growth & Forecast (2024-2032)

Description

Microtomes Market Synopsis:

Microtomes Market Size Was Valued at USD 142.3 Million in 2023, and is Projected to Reach USD 246.6 Million by 2032, Growing at a CAGR of 6.3% From 2024-2032.

Microtomes market means the global industry of manufacturing and distributing microtomes, which are precision tools used for slicing ultra-thin sections of materials with especial reference to biological tissues for microscopy. These devices are common equipment for laboratories and research centers employed significantly in histology, pathology, and material science in preparing tissues for analysis. Popular ones are the rotary microtomes-overlay microtomes, sliding ones, and the vibrating microtomes that are suitable depending on the thickness and the forms of the specimen to be examined.

The market for microtomes has steadily grown over the last few years, primarily as a result of the higher usage of precise instruments across the world in diagnosing diseases as well as analyzing specimen in research. This growth is due to the increase in life science applications, especially pathological devices which require high quality, thin tissues for accurate diagnoses. Since health care and medical research is improving daily, microtomes are establishing itself in the laboratories where pathologists use it for examining biological tissues. Furthermore, the increase in the average incidence of chronic diseases and the increase in life expectancy, more requires high-quality diagnostic equipment, which will stimulate the need for microtomes.

Moreover, rising incidences of research activities both in universities and companies mainly in the biomedical research and development of new materials are also contributing to the growth of the market. Emerging trends in technology are increasing the chances of having ever improved models of microtomes such as fully automated type that has increased precision, consistency and ease of its use. This advancement of technology is extending the fields of uses of microtomes with the addition of pharmaceutical, biotechnology, and even environmental fields apart from being very important in diagnosis in the medical field. Another factor is a shift towards more individualized healthcare known as personalized medicine where high quality tissue sample analysis is paramount.

Microtomes Market Trend Analysis:

Automation in Microtome Technology

Another imperative factor observed in the microtomes market is the ongoing automation and digital control change. The requirements for motorized and automated microtomes are growing because laboratories want to include consistency and speed in the tissue sectioning process. New microtomes have automated features such as buttons to adjust and program several aspects of microtome and depict results on a screen, so there is little human interferences. Automation is highly useful in a busy laboratory in which many samples must be analyzed within a short period of time. This trend will remain so especially if the medical and research fields will remain insistent on the need to do certain diagnostic and analytical solutions faster and more accurately.

Expanding Application in Precision Medicine

One key growth area to look into, for the companies playing in the microtomes market is the increasing application in precision medicine. The ongoing focus and change in the approach to delivering patient-centred care that takes into account the patient’s genome and molecular signatures makes accurate diagnostics more important than ever. When it involves the molecular identity of tissue samples, microtomes are highly essential because they enable formation of thin sections of tissues for microscopy. This capability is now being applied in cancer, genomic and targeted therapy studies. The trend in the advancement of personalized medicine programs and the focus in preventive diagnosis for diseases are considered as suitable grounds for microtome manufacturers to innovate on products that will match the growing fields.

Microtomes Market Segment Analysis:

Microtomes Market is Segmented on the basis of Product, Technology, and Region.

By Product, Microtome devices, segment is expected to dominate the market during the forecast period

Microtome has divided under product with offerings of microtome devices and accessories of microtome. The microtome devices emerged as the largest product segment in terms of market share in 2022. Availability of these systems in commercial market, as well as their high rate of adoption due to relatively simple functioning mechanisms, can be credited for dominance of the type. Sample machines available in this category include, Sakura Finetek EVO 9000, Leica RM2235, HM 525 and A550.Manufacturing Accessories segment is expected to dominate over the global pipeline and hold the largest proportion in the years to come and, the accessories segment is expected to bloom at the fastest CAGR over the forecast period. Ries. Microtome devices dominated the market with a significant share in 2022. Commercial availability of these systems and their high adoption due to ease of handling are some of the key factors that can be attributed to the dominance. Some of the products available in this category includes Sakura Finetek EVO 9000, Leica RM2235, HM 525, and A550.

The accessories segment is anticipated to grow at a fastest CAGR over the forecast period. Increasing usage of these accessories in hospitals and clinics because of easy availability is one of the key drivers that may help to increase the market significantly. Market accessories are selling more and more with a higher demand for fully automated microtomes and higher demand of microtomes in more and more labs. Determinants like portability of microtome and some other factors like some other aspects of the microtome are easy to its operation and low maintenance cost are also expected to drive growth in the coming few years.

By Technology, fully automated segment expected to held the largest share

As per technology the low implantation market is classified into fully automated low implantation, semi-automated low implantation and manually implantation. Fully automated devices were the most popular devices found in the global market in 2022 selling 51.5% of the total products and is projected to grow at the highest CAGR of 7.9% over the forecast period mainly due to increased demand for technologically advanced products especially within the developed world by countries like the U.S., Germany, France, and Japan. It noted that the fully automated devices are more accurate and have even larger throughput time than the smaller scale equipment. About the time of the September 2022, the Apeal from Tissue-Tek, improved the Genie Tissue Processor by delivering ideal slides with the identical time output by consolidating a single procedure and achieving ideal staining excellence on a full 130 + Sakura antibodies line.

Some of the growth drivers observed are the availability of large fully automated systems in the commercial market and the growing need for tissue diagnostic procedures in the digital platform in the next few years. Few of the Microtome are A550, Genie, and HistoCore AUTOCUT 2550 by Leica Biosystems.

This is due to the growing hospital and research laboratory adoption of routine tissue examinations due to the perceived early diagnosis advantages in a number of diseases, including cancer, is one of the drivers expected to propel the market growth in the future. Further, the rise in lab workload in histopathology is likely to add to the level of automation in tissue diagnostics due to the need to enhance the productivity in this area, while still maintaining sample quality. Some of the factors which could positively impact the histopathology industry, and therefore create a positive outlook for the market growth in the future are the increased incidences of cancer, increased global geriatric population, and the trends of seeking early disease diagnosis.

Microtomes Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

The regional study observed that in 2023 North American market has a major market share in the microtomes market. The region contributes to almost half of the global demand for medical and research instruments which is backed by highly developed infrastructure of the healthcare system, active research and development, and rising focus on precise diagnosis. The United States has a vast potential of highly developed medical facilities and research laboratories using advanced histological services and product requirements such as microtomes.

In addition, North America has a large share of the market because several large manufacturers of microtomes are also located in the area along with established distribution networks. It is expected that North America will account for a market share of 35-40% in 2023, particularly as over the next years there is expected to be developments of new medical technologies and applications of medical research.

Active Key Players in the Microtomes Market

Agilent Technologies (United States)

Biocut Technologies (Singapore)

Boeckeler Instruments (United States)

Bright Instrument Company Ltd. (United Kingdom)

Cambridge Bioscience (United Kingdom)

Dako (Denmark)

Hitachi High-Tech Corporation (Japan)

Leica Biosystems (Germany)

MTI-GlobalStem (United States)

Reichert Technologies (United States)

RMC Boeckeler (United States)

Sakura Finetek Japan (Japan)

Ted Pella Inc. (United States)

Thermo Fisher Scientific (United States)

Zhenjiang Xinyuan Microtome Co., Ltd. (China)

Other Active Players